ZNF217: the cerberus who fails to guard the gateway to lethal malignancy.
Year: 2021
Type: review
Abstract: A regulation and cancer immune response triggered significant attention while lacking critical evidence. Thus, in this review, we revisit the literature about ZNF217 and emphasize its importance as a prognostic biomarker for early prevention and as a therapeutic target.
Source: PubMed
Authors: Yingpu Li, Hao Wu, Qin Wang, Shouping Xu
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W3187097071
